{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:31:54Z","timestamp":1794411114336,"version":"4.9.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62248-1","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:32:03Z","timestamp":1753439523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Identifying fibroblast-derived sFRP2 as a therapeutic target and engineering siRNA therapy for uterine scarring"],"prefix":"10.1038","volume":"16","author":[{"given":"Juan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zedan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanfang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4911-7942","authenticated-orcid":false,"given":"Hongbo","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-2947","authenticated-orcid":false,"given":"Jianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"62248_CR1","doi-asserted-by":"publisher","first-page":"11998","DOI":"10.3390\/ijerph182211998","volume":"18","author":"A Stupak","year":"2021","unstructured":"Stupak, A., Kondracka, A., Fronczek, A. & Kwasniewska, A. Scar tissue after a cesarean section-the management of different complications in pregnant women. Int. J. Environ. Res. Public Health 18, 11998 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"62248_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.17219\/acem\/169236","volume":"33","author":"K Olszewska","year":"2023","unstructured":"Olszewska, K., Ptak, A., Rusak, A., Debiec-Bak, A. & Stefanska, M. Changes in the scar tissue structure after cesarean section as a result of manual therapy. Adv. Clin. Exp. Med. 33, 387\u2013385 (2023).","journal-title":"Adv. Clin. Exp. Med."},{"key":"62248_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(18)31928-7","volume":"392","author":"T Boerma","year":"2018","unstructured":"Boerma, T. et al. Global epidemiology of use of and disparities in caesarean sections. Lancet 392, 1341\u20131348 (2018).","journal-title":"Lancet"},{"key":"62248_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/ajo.12497","volume":"57","author":"CY Liao","year":"2017","unstructured":"Liao, C. Y., Tse, J., Sung, S. Y., Chen, S. H. & Tsui, W. H. Cornual wedge resection for interstitial pregnancy and postoperative outcome. Aust. N. Z. J. Obstet. Gynaecol. 57, 342\u2013345 (2017).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"62248_CR5","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2147\/IJWH.S422187","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang, S., Hu, Q., Liao, H., Wang, K. & Yu, H. Perinatal outcomes of pregnancy in women with scarred uteri. Int. J. Womens Health 15, 1453\u20131465 (2023).","journal-title":"Int. J. Womens Health"},{"key":"62248_CR6","doi-asserted-by":"publisher","first-page":"103221","DOI":"10.1016\/j.rbmo.2023.04.012","volume":"47","author":"A Mohr-Sasson","year":"2023","unstructured":"Mohr-Sasson, A. et al. The association between uterine scar defect (niche) and the presence of symptoms. Reprod. Biomed. Online 47, 103221 (2023).","journal-title":"Reprod. Biomed. Online"},{"key":"62248_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejogrb.2023.06.030","volume":"288","author":"B Silva","year":"2023","unstructured":"Silva, B., Viana Pinto, P. & Costa, M. A. Cesarean scar pregnancy: a systematic review on expectant management. Eur. J. Obstet. Gynecol. Reprod. Biol. 288, 36\u201343 (2023).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"62248_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejogrb.2021.05.010","volume":"262","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. Outcomes of reproduction following cesarean scar pregnancy treatment: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 262, 80\u201392 (2021).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"62248_CR9","doi-asserted-by":"publisher","first-page":"bqaa174","DOI":"10.1210\/endocr\/bqaa174","volume":"161","author":"ZL Li","year":"2020","unstructured":"Li, Z. L. et al. Uterine scarring leads to adverse pregnant consequences by impairing the endometrium response to steroids. Endocrinology 161, bqaa174 (2020).","journal-title":"Endocrinology"},{"key":"62248_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01485-w","volume":"28","author":"Q Sun","year":"2023","unstructured":"Sun, Q., Tang, L. & Zhang, D. Molecular mechanisms of uterine incision healing and scar formation. Eur. J. Med. Res. 28, 496 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"62248_CR11","doi-asserted-by":"publisher","first-page":"633180","DOI":"10.3389\/fcell.2021.633180","volume":"9","author":"A Navarro","year":"2021","unstructured":"Navarro, A., Bariani, M. V., Yang, Q. & Al-Hendy, A. Understanding the impact of uterine fibroids on human endometrium function. Front. Cell Dev. Biol. 9, 633180 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"62248_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","volume":"16","author":"S Barrientos","year":"2008","unstructured":"Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H. & Tomic-Canic, M. Growth factors and cytokines in wound healing. Wound Repair Regen. 16, 585\u2013601 (2008).","journal-title":"Wound Repair Regen."},{"key":"62248_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23304-8","volume":"12","author":"F Shams","year":"2022","unstructured":"Shams, F. et al. Overexpression of VEGF in dermal fibroblast cells accelerates the angiogenesis and wound healing function: in vitro and in vivo studies. Sci. Rep. 12, 18529 (2022).","journal-title":"Sci. Rep."},{"key":"62248_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-\u03b2: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"62248_CR15","doi-asserted-by":"publisher","first-page":"e174598","DOI":"10.1172\/JCI174598","volume":"134","author":"ML Cohen","year":"2024","unstructured":"Cohen, M. L. et al. A fibroblast-dependent TGF-\u03b21\/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis. J. Clin. Invest. 134, e174598 (2024).","journal-title":"J. Clin. Invest."},{"key":"62248_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncb1811","volume":"11","author":"K Kobayashi","year":"2009","unstructured":"Kobayashi, K. et al. Secreted frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat. Cell Biol. 11, 46\u201355 (2009).","journal-title":"Nat. Cell Biol."},{"key":"62248_CR17","doi-asserted-by":"publisher","first-page":"166933","DOI":"10.1016\/j.bbadis.2023.166933","volume":"1870","author":"D Lv","year":"2024","unstructured":"Lv, D. et al. sFRP2 promotes renal dysfunction of diabetic kidney disease via modulating Fzd5-induced cytosolic calcium ion concentration and CaMKII\/Mek\/Erk pathway in mesangial cells. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 166933 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"62248_CR18","doi-asserted-by":"publisher","first-page":"712217","DOI":"10.3389\/fendo.2021.712217","volume":"12","author":"H Guan","year":"2021","unstructured":"Guan, H. et al. Secreted frizzled related proteins in cardiovascular and metabolic diseases. Front. Endocrinol. 12, 712217 (2021).","journal-title":"Front. Endocrinol."},{"key":"62248_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41580-024-00715-1","volume":"25","author":"OA Pena","year":"2024","unstructured":"Pena, O. A. & Martin, P. Cellular and molecular mechanisms of skin wound healing. Nat. Rev. Mol. Cell Biol. 25, 599\u2013616 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"62248_CR20","doi-asserted-by":"publisher","first-page":"2251847","DOI":"10.1080\/21655979.2023.2251847","volume":"14","author":"S Hanuman","year":"2023","unstructured":"Hanuman, S., Pande, G. & Nune, M. Current status and challenges in uterine myometrial tissue engineering. Bioengineered 14, 2251847 (2023).","journal-title":"Bioengineered"},{"key":"62248_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41572-023-00474-x","volume":"9","author":"MG Jeschke","year":"2023","unstructured":"Jeschke, M. G. et al. Scars. Nat. Rev. Dis. Prim. 9, 64 (2023).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"62248_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","volume":"16","author":"B Hinz","year":"2020","unstructured":"Hinz, B. & Lagares, D. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases. Nat. Rev. Rheumatol. 16, 11\u201331 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"62248_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3, 349\u2013363 (2002).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"62248_CR24","doi-asserted-by":"publisher","first-page":"eadj9559","DOI":"10.1126\/sciadv.adj9559","volume":"10","author":"Y Xu","year":"2024","unstructured":"Xu, Y., Ying, L., Lang, J. K., Hinz, B. & Zhao, R. Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy. Sci. Adv. 10, eadj9559 (2024).","journal-title":"Sci. Adv."},{"key":"62248_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s12276-022-00778-0","volume":"54","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z. et al. TGF-\u03b2 promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2\/3 and Akt\/mTOR pathways. Exp. Mol. Med. 54, 673\u2013684 (2022).","journal-title":"Exp. Mol. Med."},{"key":"62248_CR26","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis, N. Transforming growth factor-\u03b2 in tissue fibrosis. J. Exp. Med. 217, e20190103 (2020).","journal-title":"J. Exp. Med."},{"key":"62248_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/path.5680","volume":"254","author":"EH Budi","year":"2021","unstructured":"Budi, E. H., Schaub, J. R., Decaris, M., Turner, S. & Derynck, R. TGF-\u03b2 as a driver of fibrosis: physiological roles and therapeutic opportunities. J. Pathol. 254, 358\u2013373 (2021).","journal-title":"J. Pathol."},{"key":"62248_CR28","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1073\/pnas.0610024104","volume":"104","author":"M Mirotsou","year":"2007","unstructured":"Mirotsou, M. et al. Secreted frizzled related protein 2 (sFRP2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl. Acad. Sci. USA 104, 1643\u20131648 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62248_CR29","doi-asserted-by":"publisher","first-page":"14602","DOI":"10.1074\/jbc.M309008200","volume":"279","author":"JL Lee","year":"2004","unstructured":"Lee, J. L., Lin, C. T., Chueh, L. L. & Chang, C. J. Autocrine\/paracrine secreted frizzled-related protein 2 induces cellular resistance to apoptosis: a possible mechanism of mammary tumorigenesis. J. Biol. Chem. 279, 14602\u201314609 (2004).","journal-title":"J. Biol. Chem."},{"key":"62248_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00716-5","volume":"8","author":"Q Wang","year":"2024","unstructured":"Wang, Q., Zhao, Y., Tan, G. & Ai, J. Single cell analysis revealed sFRP2 cancer associated fibroblasts drive tumorigenesis in head and neck squamous cell carcinoma. NPJ Precis. Oncol. 8, 228 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"62248_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10555-020-09941-3","volume":"40","author":"K Van Loon","year":"2021","unstructured":"Van Loon, K., Huijbers, E. J. M. & Griffioen, A. W. Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis. Cancer Metastasis Rev. 40, 191\u2013203 (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"62248_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1734","volume":"3","author":"A Akhmetshina","year":"2012","unstructured":"Akhmetshina, A. et al. Activation of canonical Wnt signalling is required for TGF-\u03b2-mediated fibrosis. Nat. Commun. 3, 735 (2012).","journal-title":"Nat. Commun."},{"key":"62248_CR33","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41569-022-00718-5","volume":"19","author":"I Akoumianakis","year":"2022","unstructured":"Akoumianakis, I., Polkinghorne, M. & Antoniades, C. Non-canonical Wnt signalling in cardiovascular disease: mechanisms and therapeutic implications. Nat. Rev. Cardiol. 19, 783\u2013797 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"62248_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1369\/0022155415617988","volume":"64","author":"DR Newman","year":"2016","unstructured":"Newman, D. R. et al. Expression of Wnt5a in idiopathic pulmonary fibrosis and its control by TGF-\u03b2 and Wnt7b in human lung fibroblasts. J. Histochem. Cytochem. 64, 99\u2013111 (2016).","journal-title":"J. Histochem. Cytochem."},{"key":"62248_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1748-1716.2011.02294.x","volume":"204","author":"A Kikuchi","year":"2012","unstructured":"Kikuchi, A., Yamamoto, H., Sato, A. & Matsumoto, S. Wnt5a: its signalling, functions and implication in diseases. Acta Physiol. 204, 17\u201333 (2012).","journal-title":"Acta Physiol."},{"key":"62248_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s42003-024-05881-8","volume":"7","author":"THN Tran","year":"2024","unstructured":"Tran, T. H. N. et al. Soluble frizzled-related proteins promote exosome-mediated Wnt re-secretion. Commun. Biol. 7, 254 (2024).","journal-title":"Commun. Biol."},{"key":"62248_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41374-019-0341-7","volume":"100","author":"CC Chung","year":"2020","unstructured":"Chung, C. C. et al. Vascular endothelial growth factor enhances profibrotic activities through modulation of calcium homeostasis in human atrial fibroblasts. Lab. Invest. 100, 285\u2013296 (2020).","journal-title":"Lab. Invest."},{"key":"62248_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-780","volume":"7","author":"Y Tokuda","year":"2014","unstructured":"Tokuda, Y., Tanaka, M., Yagi, T. & Tashiro, K. The defect of sFRP2 modulates an influx of extracellular calcium in B lymphocytes. BMC Res. Notes 7, 780 (2014).","journal-title":"BMC Res. Notes"},{"key":"62248_CR39","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1016\/j.cell.2023.05.022","volume":"186","author":"AN Nabhan","year":"2023","unstructured":"Nabhan, A. N. et al. Targeted alveolar regeneration with Frizzled-specific agonists. Cell 186, 2995\u20133012 (2023).","journal-title":"Cell"},{"key":"62248_CR40","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/s41401-023-01070-1","volume":"44","author":"M-J Huang","year":"2023","unstructured":"Huang, M.-J. et al. Targeted VEGFA therapy in regulating early acute kidney injury and late fibrosis. Acta Pharmacol. Sin. 44, 1815\u20131825 (2023).","journal-title":"Acta Pharmacol. Sin."},{"key":"62248_CR41","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817\u2013838 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62248_CR42","first-page":"100845","volume":"18","author":"A Kumari","year":"2023","unstructured":"Kumari, A., Kaur, A. & Aggarwal, G. The emerging potential of siRNA nanotherapeutics in treatment of arthritis. Asian J. Pharm. Sci. 18, 100845 (2023).","journal-title":"Asian J. Pharm. Sci."},{"key":"62248_CR43","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1016\/j.apsb.2022.11.026","volume":"13","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Lipid carriers for mRNA delivery. Acta Pharm. Sin. B 13, 4105\u20134126 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"62248_CR44","doi-asserted-by":"publisher","first-page":"100041","DOI":"10.1016\/j.pscia.2024.100041","volume":"2","author":"D Lu","year":"2024","unstructured":"Lu, D., Sun, Y., Luan, Y. & He, W. Rational design of siRNA-based delivery systems for effective treatment of brain diseases. Pharm. Sci. Adv. 2, 100041 (2024).","journal-title":"Pharm. Sci. Adv."},{"key":"62248_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","volume":"361","author":"SH El Moukhtari","year":"2023","unstructured":"El Moukhtari, S. H. et al. Lipid nanoparticles for siRNA delivery in cancer treatment. J. Control. Release 361, 130\u2013146 (2023).","journal-title":"J. Control. Release"},{"key":"62248_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23571-5","volume":"12","author":"D Monsivais","year":"2021","unstructured":"Monsivais, D. et al. Endometrial receptivity and implantation require uterine BMP signaling through an ACVR2A-SMAD1\/SMAD5 axis. Nat. Commun. 12, 3386 (2021).","journal-title":"Nat. Commun."},{"key":"62248_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39008-0","volume":"14","author":"SC Yang","year":"2023","unstructured":"Yang, S. C. et al. CFP1 governs uterine epigenetic landscapes to intervene in progesterone responses for uterine physiology and suppression of endometriosis. Nat. Commun. 14, 3220 (2023).","journal-title":"Nat. Commun."},{"key":"62248_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.placenta.2014.02.012","volume":"35","author":"AE Guttmacher","year":"2014","unstructured":"Guttmacher, A. E., Maddox, Y. T. & Spong, C. Y. The human placenta project: placental structure, development, and function in real time. Placenta 35, 303\u2013304 (2014).","journal-title":"Placenta"},{"key":"62248_CR49","doi-asserted-by":"publisher","first-page":"399.e1","DOI":"10.1016\/j.ajog.2021.08.056","volume":"226","author":"E Jauniaux","year":"2022","unstructured":"Jauniaux, E. et al. Development of the utero-placental circulation in cesarean scar pregnancies: a case-control study. Am. J. Obstet. Gynecol. 226, 399.e1\u2013399.e10 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"62248_CR50","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/aogs.13834","volume":"99","author":"C Jansen","year":"2020","unstructured":"Jansen, C. et al. Development of placental abnormalities in location and anatomy. Acta Obstet. Gynecol. Scand. 99, 983\u2013993 (2020).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"62248_CR51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282\u2013300 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"62248_CR52","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. & Anderson, D. G. The clinical progress of mRNA vaccines and immunotherapies. Nat. Biotechnol. 40, 840\u2013854 (2022).","journal-title":"Nat. Biotechnol."},{"key":"62248_CR53","doi-asserted-by":"crossref","unstructured":"Li, J., Jung, W., Nam, S., Chaudhuri, O. & Kim, T. in Multi-scale Extracellular Matrix Mechanics and Mechanobiology (ed. Zhang, Y.) 247\u2013282 (Springer International Publishing, 2020).","DOI":"10.1007\/978-3-030-20182-1_8"},{"key":"62248_CR54","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1091\/mbc.E14-12-1618","volume":"26","author":"JY Sim","year":"2015","unstructured":"Sim, J. Y. et al. Spatial distribution of cell\u2013cell and cell\u2013ECM adhesions regulates force balance while maintaining E-cadherin molecular tension in cell pairs. Mol. Biol. Cell. 26, 2456\u20132465 (2015).","journal-title":"Mol. Biol. Cell."},{"key":"62248_CR55","doi-asserted-by":"publisher","first-page":"C531","DOI":"10.1152\/ajpcell.00238.2013","volume":"306","author":"M Mastri","year":"2014","unstructured":"Mastri, M. et al. Secreted frizzled-related protein 2 as a target in antifibrotic therapeutic intervention. Am. J. Physiol. Cell Physiol. 306, C531\u2013C539 (2014).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"62248_CR56","doi-asserted-by":"publisher","first-page":"21110","DOI":"10.1073\/pnas.1004708107","volume":"107","author":"W He","year":"2010","unstructured":"He, W. et al. Exogenously administered secreted frizzled related protein 2 (sFRP2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc. Natl. Acad. Sci. USA 107, 21110\u201321115 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62248_CR57","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.celrep.2019.07.023","volume":"28","author":"CJ Liang","year":"2019","unstructured":"Liang, C. J. et al. sFRPs are biphasic modulators of Wnt-signaling-elicited cancer stem cell properties beyond extracellular control. Cell Rep. 28, 1511\u20131525 e1515 (2019).","journal-title":"Cell Rep."},{"key":"62248_CR58","doi-asserted-by":"publisher","first-page":"C710","DOI":"10.1152\/ajpcell.00137.2016","volume":"311","author":"H Lin","year":"2016","unstructured":"Lin, H. et al. sFRP2 activates Wnt\/\u03b2-catenin signaling in cardiac fibroblasts: differential roles in cell growth, energy metabolism, and extracellular matrix remodeling. Am. J. Physiol. Cell Physiol. 311, C710\u2013C719 (2016).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"62248_CR59","doi-asserted-by":"publisher","first-page":"730","DOI":"10.7150\/ijbs.40923","volume":"16","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Multiple roles of sFRP2 in cardiac development and cardiovascular disease. Int. J. Biol. Sci. 16, 730\u2013738 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"62248_CR60","doi-asserted-by":"publisher","first-page":"115344","DOI":"10.1016\/j.biopha.2023.115344","volume":"166","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Secreted frizzled-related proteins: a promising therapeutic target for cancer therapy through Wnt signaling inhibition. Biomed. Pharmacother. 166, 115344 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"62248_CR61","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2022.06.013","volume":"40","author":"BM Murphy","year":"2022","unstructured":"Murphy, B. M. & Burd, C. E. The aging lung microenvironment awakens melanoma metastases. Cancer Cell 40, 815\u2013817 (2022).","journal-title":"Cancer Cell"},{"key":"62248_CR62","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature17392","volume":"532","author":"A Kaur","year":"2016","unstructured":"Kaur, A. et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature 532, 250\u2013254 (2016).","journal-title":"Nature"},{"key":"62248_CR63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s42003-019-0432-4","volume":"2","author":"M Mehmeti","year":"2019","unstructured":"Mehmeti, M. et al. Wnt5a is a TLR2\/4-ligand that induces tolerance in human myeloid cells. Commun. Biol. 2, 176 (2019).","journal-title":"Commun. Biol."},{"key":"62248_CR64","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/humrep\/dey026","volume":"33","author":"T Heinosalo","year":"2018","unstructured":"Heinosalo, T. et al. Secreted frizzled-related protein 2 (sFRP2) expression promotes lesion proliferation via canonical Wnt signaling and indicates lesion borders in extraovarian endometriosis. Hum. Reprod. 33, 817\u2013831 (2018).","journal-title":"Hum. Reprod."},{"key":"62248_CR65","doi-asserted-by":"publisher","first-page":"15561","DOI":"10.1074\/jbc.M308759200","volume":"279","author":"JL Gooch","year":"2004","unstructured":"Gooch, J. L., Gorin, Y., Zhang, B. X. & Abboud, H. E. Involvement of calcineurin in transforming growth factor-\u03b2-mediated regulation of extracellular matrix accumulation. J. Biol. Chem. 279, 15561\u201315570 (2004).","journal-title":"J. Biol. Chem."},{"key":"62248_CR66","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13287-017-0535-0","volume":"8","author":"L Xu","year":"2017","unstructured":"Xu, L. et al. Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars. Stem Cell Res. Ther. 8, 84 (2017).","journal-title":"Stem Cell Res. Ther."},{"key":"62248_CR67","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.biomaterials.2011.11.038","volume":"33","author":"N Lin","year":"2012","unstructured":"Lin, N. et al. The effect of collagen-binding vascular endothelial growth factor on the remodeling of scarred rat uterus following full-thickness injury. Biomaterials 33, 1801\u20131807 (2012).","journal-title":"Biomaterials"},{"key":"62248_CR68","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1021\/ja301621z","volume":"134","author":"D Chen","year":"2012","unstructured":"Chen, D. et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948\u20136951 (2012).","journal-title":"J. Am. Chem. Soc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62248-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62248-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62248-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:56:58Z","timestamp":1757293018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62248-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62248"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62248-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.X.Z., H.B.Q., J.C., and S.Q.Z. are inventors in a pending patent filed by the China National Intellectual Property Administration (No. 202411591577.4, November 08 2024) related to sFRP2 as a therapeutic target and sisFRP2 therapies, but the rights belong to the Army Medical University and First Affiliated Hospital of Chongqing Medical University. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6850"}}